NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-300-2009-1-US-01 Neutralizing Antibodies Against HIV-1 And Their Use US 61/252,613 Abandoned
NIAID E-007-2010-0-US-01 Unique Method For Designing Expandable HIV Mosaic Vaccines To Allow For Improved Response To Newly Identified Epitopes US 61/252,545 Abandoned
NIAID E-018-2010-0-US-01 Plasmid Shuttle Vector For Insertion Of Foreign Genes Into Del LIl Site Of Modi Fied Vaccinia Virus Ankara (MVA) To Increase Stability Of Foreign Gene Expression In This Site US 61/252,326 Abandoned
NIDDK E-219-2011-2-PCT-01 CLINICAL DECISION MODEL PCT PCT COMB PCT/US2009/060850 Abandoned
NCI E-339-2002-0-US-04 Method and Apparatus for Performing Multiple Simultaneous Manipulations of Biomolecules In A Two-Dimensional Array US CON 12/587,976 8283158 Abandoned PDF
NIMH E-274-2015-0-US-01 DT390-EGF Fusion Protein For Treatment Of EGF Receptor Positive Cancers US 61/251,676 Abandoned
NIAID E-010-2011-0-US-01 Recombinant MVA Viruses Expressing Clades A/G, B, And C Modified HIV env, Gag And Pol Genes; Recombinant MVA Expressing GM-CSF. US 61/251,119 Abandoned
NCI E-065-2005-1-US-02 NOVOBIOCIN ANALOGUES AS NEUROPROTECTIVE AGENTS AND IN THE TREATMENT OF AUTOIMMUNE DISORDERS US CON 12/577,620 7960353 Expired PDF
NCI E-158-2009-0-US-01 Granulysin Immunotherapy US 61/250,601 Abandoned
NCI E-322-2008-0-EP-04 Method of Making A Vaccine EP National Stage 09820027.2 Abandoned
NCI E-322-2008-0-PCT-02 Method For AIDS Vaccine PCT PCT PCT/US09/060303 Expired
NCATS E-326-2008-0-CA-19 Activators Of Human Pyruvate Kinase CA DIV 3041868 Issued
NCATS E-326-2008-0-CA-04 Activators Of Human Pyruvate Kinase CA National Stage 2740148 Issued
NCATS E-326-2008-0-EP-13 Activators Of Human Pyruvate Kinase EP DIV 16207004.9 Issued
NCATS E-326-2008-0-EP-05 Activators Of Human Pyruvate Kinase EP National Stage 09740795.1 Issued
NCATS E-326-2008-0-DE-14 Activators Of Human Pyruvate Kinase DE EP 09740795.1 Issued
NCATS E-326-2008-0-FR-16 Activators Of Human Pyruvate Kinase FR EP 09740795.1 Issued
NCATS E-326-2008-0-ES-15 Activators Of Human Pyruvate Kinase ES EP 09740795.1 Issued
NCATS E-326-2008-0-GB-17 Activators Of Human Pyruvate Kinase GB EP 09740795.1 Issued
NCATS E-326-2008-0-IT-18 Activators Of Human Pyruvate Kinase IT EP 09740795.1 Issued
NCATS E-326-2008-0-AU-03 Activators Of Human Pyruvate Kinase AU National Stage 2009303335 Issued
NCATS E-326-2008-0-JP-06 Activators Of Human Pyruvate Kinase JP National Stage 2011-531221 Issued
NIAID E-003-2009-0-PCT-02 Use Of HIV Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope PCT PCT PCT/US2009/060167 Expired
NCATS E-326-2008-0-PCT-02 Activators Of Human Pyruvate Kinase PCT PCT PCT/US2009/060237 Expired
NCI E-232-2009-0-US-01 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System US 61/249,476 Abandoned
NIAID E-159-2007-3-US-03 Monoclonal Antibodies Against Dengue And Other Viruses With Deletion Of Fc Region US National Stage 12/594,756 8337854 Abandoned PDF
NIAID E-006-2010-0-US-01 Mechanisms For Protection Against Pandemic Strains Of Influenza US 61/248,835 Abandoned
NCI E-010-2008-0-PCT-02 Novel Protein Delivery System For Mammalian Cells PCT PCT PCT/US2009/59328 Expired
NCI E-282-2008-1-PCT-01 Identification Of A Three-gene Expression Signature Predictive Of Response To Cisplatin And Fluorouracil Combination Chemotherapy PCT PCT COMB PCT/US2009/059423 Abandoned
NIDDK E-068-2010-0-US-01 Genotype 1b Hepatitis C Virus Cell Culture System. US 61/248,229 Abandoned
NIAID E-165-2009-0-US-01 Reprogramming Of Somatic Cells By BORIS Gene US 61/248,286 Abandoned
NIAID E-043-2010-0-DK-01 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof DK ORD PA200970143 Pending
NICHD E-339-2008-2-CN-02 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia CN National Stage 200980148315.8 Abandoned
NCI E-065-2005-0-US-05 Novobiocin Analogues as Anticancer Agents US CON 12/571,899 7811998 Issued PDF
NICHD E-339-2008-2-PCT-01 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. PCT PCT COMB PCT/US2009/059284 Expired
NICHD E-339-2008-2-EP-03 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. EP National Stage 09818532.5 Abandoned
NICHD E-339-2008-2-IN-04 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. IN National Stage 1382/KOLNP/2011 Abandoned
NIDCR E-117-2009-0-US-01 Long-acting Ophthalmic Analgesic Eye Drops US 61/247,881 Abandoned
NCATS E-230-2009-0-US-01 Substituted Quinazolin-4-amine Based Inhibitors Of DyrklA (Dual-specificity Tyrosine-(Y)-phosphorylation Regulated Kinase LA) US 61/247,632 Abandoned
NCI E-205-2009-0-US-01 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US 61/247,625 Abandoned
NCI E-146-2007-1-US-01 Selenocysteine Mediated Hybrid Antibody Molecules US CIP 12/570,796 8916159 Abandoned PDF
NIA E-241-2008-0-US-03 PHENSERINE AND POSIPHEN FOR TREATING NEUROPSYCHIATRIC AND NEURODEGENERATIVE CONDITIONS US National Stage 13/262,044 8875851 Issued PDF
NHLBI E-178-2004-0-US-03 Infectious Clone Of Human Parvovirus B19 And Methods US DIV 12/569,848 8603784 Issued PDF
NIAID E-158-2007-3-US-02 Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae US National Stage 12/593,818 8298541 Abandoned PDF
NCI E-206-1995-3-US-13 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY US DIV 12/569,821 7939639 Abandoned PDF
NCI E-090-2000-1-US-07 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 US DIV 12/568,134 8754046 Expired PDF
NIAID E-005-2009-1-PCT-01 Flavivirus-Based System For Production Of Hepatitis C Virus (HCV) PCT PCT COMB PCT/US09/58598 Expired
NLM E-107-2010-2-PCT-01 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS PCT PCT COMB PCT/US2009/058562 Expired
NCI E-051-2009-0-PCT-02 Large-scale protein sample collection method PCT PCT PCT/JP09/066811 Abandoned
NIMH E-245-2006-0-US-03 Schizophrenia-Related Isoform Of KCNH2 For The Development Of Antipsychotic Drugs US National Stage 12/593,159 8101380 Abandoned PDF